Mite and pet allergen exposure in hotels in Uberlândia, Midwestern Brazil

E C Simplício1, D A O Silva, I A Braga

  • 1Laboratory of Allergy and Clinical Immunology, Biomedical Science Institute, Federal University of Uberlândia, Uberlândia, MG, Brazil.

Indoor Air
|July 31, 2007
PubMed
Abstract

Insights

House dust mite allergens, particularly Der f 1, are prevalent in Uberlândia hotels, especially in bedding. These high allergen levels pose a risk for guests with respiratory allergies.

Area of Science:

  • Environmental Science
  • Allergy and Immunology
  • Public Health

Background:

  • Mite allergens are significant triggers for airway sensitization and allergic diseases.
  • Indoor environments, including hotels, can act as reservoirs for common allergens.

Purpose of the Study:

  • To quantify exposure to house dust mite (Der p 1, Der f 1) and pet (Fel d 1, Can f 1) allergens in hotel dust samples.
  • To identify the predominant allergen and its location within hotel rooms in Uberlândia, Brazil.

Main Methods:

  • Collected 140 dust samples from bedding and carpets in 20 hotels.
  • Measured allergen levels using established immunological methods.
  • Analyzed allergen concentrations in relation to hotel class and sample type (bedding vs. carpet).

Main Results:

  • Der f 1 was the predominant mite allergen, with significantly higher levels in bedding (11.30 µg/g) compared to carpets (6.32 µg/g).
  • High Der f 1 levels (>10 µg/g) were found in a majority of samples across all hotel classes.
  • Pet allergen levels (Fel d 1, Can f 1) were relatively low.

Conclusions:

  • Hotels in Uberlândia exhibit high levels of Der f 1, posing a significant risk for guests with mite sensitization.
  • Hotel environments should be considered in allergen avoidance strategies for individuals with respiratory allergies.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...